Mr. Diao HaiPeng

Mr. DIAO Haipeng graduated from Biology Department of Xiamen University. He was responsible for insulin development and sales from 1988 to 1995 in Jiangsu Wan Bang Biochemistry Pharmaceutical Co., Ltd. In his 21-year service at Luye Pharma as a senior management executive, Mr. DIAO took in charge of marketing, sales, merge and investment. He was engaged in Luye Pharma’s listing project in Singapore, and responsible for acquisition project in Nanjing. Mr. DIAO took the post of Vice President of Luye Life Sciences Group in January 2017, accountable for strategic planning and investment of the Group and the business of Luye Diagnosis. He was assigned as the Chairman of Luye Medical (China) and Acting CEO in June 2018.
Mr. DIAO Haipeng graduated from Biology Department of Xiamen University. He was responsible for insulin development and sales from 1988 to 1995 in Jiangsu Wan Bang Biochemistry Pharmaceutical Co., Ltd. In his 21-year service at Luye Pharma as a senior management executive, Mr. DIAO took in charge of marketing, sales, merge and investment. He was engaged in Luye Pharma’s listing project in Singapore, and responsible for acquisition project in Nanjing. Mr. DIAO took the post of Vice President of Luye Life Sciences Group in January 2017, accountable for strategic planning and investment of the Group and the business of Luye Diagnosis. He was assigned as the Chairman of Luye Medical (China) and Acting CEO in June 2018.